Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.55)
# 2,332
Out of 5,067 analysts
270
Total ratings
49.39%
Success rate
-0.54%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Outperform | $410 → $405 | $370.22 | +9.39% | 13 | Oct 31, 2025 | |
| ILMN Illumina | Maintains: Outperform | $132 → $142 | $125.96 | +12.73% | 9 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $88 → $92 | $84.71 | +8.61% | 15 | Oct 31, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $88 → $92 | $78.24 | +17.59% | 5 | Oct 30, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $17 → $18 | $15.45 | +16.50% | 11 | Oct 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $16 → $14 | $11.51 | +21.63% | 12 | Oct 30, 2025 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $155 → $168 | $166.64 | +0.82% | 8 | Oct 16, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $144 → $142 | $127.19 | +11.64% | 17 | Oct 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $106 → $104 | $93.52 | +11.21% | 14 | Oct 7, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $46 → $42 | $29.33 | +43.20% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $586.07 | +0.67% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $106 | $100.58 | +5.39% | 3 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $285 | $298.11 | -4.40% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,470.14 | -4.77% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $535 → $450 | $568.48 | -20.84% | 14 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $175 | $183.21 | -4.48% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $68 | $101.01 | -32.68% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $226.98 | +7.94% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $110 | $98.04 | +12.20% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $18.18 | +70.52% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $128 → $140 | $153.60 | -8.85% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $69 → $78 | $74.76 | +4.33% | 16 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $49 → $54 | $47.75 | +13.09% | 7 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $25.15 | +59.05% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $35 → $33 | $36.70 | -10.08% | 8 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $103.20 | +2.71% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $29.60 | +55.41% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.42 | +23.97% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $12.53 | +139.43% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $399.54 | -11.15% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $77.74 | +105.81% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $190.96 | +51.86% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.11 | +530.63% | 1 | May 31, 2022 |
Stryker
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $370.22
Upside: +9.39%
Illumina
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $125.96
Upside: +12.73%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $84.71
Upside: +8.61%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $78.24
Upside: +17.59%
Bausch + Lomb
Oct 30, 2025
Maintains: Outperform
Price Target: $17 → $18
Current: $15.45
Upside: +16.50%
Avantor
Oct 30, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $11.51
Upside: +21.63%
J.B. Hunt Transport Services
Oct 16, 2025
Maintains: Outperform
Price Target: $155 → $168
Current: $166.64
Upside: +0.82%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $144 → $142
Current: $127.19
Upside: +11.64%
Zimmer Biomet Holdings
Oct 7, 2025
Maintains: In-Line
Price Target: $106 → $104
Current: $93.52
Upside: +11.21%
Twist Bioscience
Oct 7, 2025
Maintains: Outperform
Price Target: $46 → $42
Current: $29.33
Upside: +43.20%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $586.07
Upside: +0.67%
Oct 7, 2025
Maintains: Outperform
Price Target: $108 → $106
Current: $100.58
Upside: +5.39%
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $298.11
Upside: -4.40%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,470.14
Upside: -4.77%
Oct 7, 2025
Maintains: In-Line
Price Target: $535 → $450
Current: $568.48
Upside: -20.84%
Oct 7, 2025
Maintains: In-Line
Price Target: $185 → $175
Current: $183.21
Upside: -4.48%
Oct 7, 2025
Maintains: Outperform
Price Target: $64 → $68
Current: $101.01
Upside: -32.68%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $226.98
Upside: +7.94%
Oct 7, 2025
Maintains: Outperform
Price Target: $115 → $110
Current: $98.04
Upside: +12.20%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $18.18
Upside: +70.52%
Oct 7, 2025
Maintains: In-Line
Price Target: $128 → $140
Current: $153.60
Upside: -8.85%
Oct 7, 2025
Upgrades: Outperform
Price Target: $69 → $78
Current: $74.76
Upside: +4.33%
Sep 30, 2025
Maintains: In-Line
Price Target: $49 → $54
Current: $47.75
Upside: +13.09%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $25.15
Upside: +59.05%
Aug 5, 2025
Maintains: In-Line
Price Target: $35 → $33
Current: $36.70
Upside: -10.08%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $103.20
Upside: +2.71%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $29.60
Upside: +55.41%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.42
Upside: +23.97%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $12.53
Upside: +139.43%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $399.54
Upside: -11.15%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $77.74
Upside: +105.81%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $190.96
Upside: +51.86%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.11
Upside: +530.63%